James F. Cummings is Chief Medical Officer of Vaxart, Inc.. Currently has a direct ownership of 326,801 shares of VXRT, which is worth approximately $290,852. The most recent transaction as insider was on Mar 28, 2024, when has been sold 3,292 shares (Common Stock) at a price of $1.3 per share, resulting in proceeds of $4,279. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 327K
0% 3M change
37.25% 12M change
Total Value Held $290,852

James F. Cummings Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 28 2024
SELL
Payment of exercise price or tax liability
$4,279 $1.3 p/Share
3,292 Reduced 1.0%
326,801 Common Stock
Mar 18 2024
BUY
Grant, award, or other acquisition
-
90,000 Added 21.42%
330,093 Common Stock
Feb 02 2024
SELL
Payment of exercise price or tax liability
$9,558 $1.2 p/Share
7,965 Reduced 3.21%
240,093 Common Stock
Dec 08 2023
SELL
Payment of exercise price or tax liability
$22,300 $0.71 p/Share
31,409 Reduced 11.24%
248,058 Common Stock
Mar 17 2023
BUY
Grant, award, or other acquisition
-
194,350 Added 44.94%
238,100 Common Stock
Mar 28 2022
BUY
Grant, award, or other acquisition
-
43,750 Added 50.0%
43,750 Common Stock
JFC

James F. Cummings

Chief Medical Officer
South San Francisco, CA

Track Institutional and Insider Activities on VXRT

Follow Vaxart, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VXRT shares.

Notify only if

Insider Trading

Get notified when an Vaxart, Inc. insider buys or sells VXRT shares.

Notify only if

News

Receive news related to Vaxart, Inc.

Track Activities on VXRT